期刊文献+

人凝血因子Ⅶ在CHO/DG44细胞中的表达 被引量:1

The expression of human coagulation factor Ⅶ in CHO/DG44 cell
原文传递
导出
摘要 PCR法扩增FⅦ基因,构建重组表达质粒FⅦ-pOptiVEC,酶切、测序鉴定.脂质体法将FⅦ-pOptiVEC质粒转入CHO/DG44细胞,并用氨甲喋呤(MTX)进行分级加压筛选,获得高表达重组FⅦ蛋白的阳性细胞克隆.亲和层析法纯化FⅦ,并通过Western-blot检测蛋白表达情况.采用FⅦ促凝活性检测试剂盒(凝固法)检测FⅦ的凝血活性.结果表明筛选出的细胞克隆能稳定表达目的蛋白,MTX加压使其表达量明显升高.促凝活性检测结果证明获得的FⅦ蛋白具有凝血活性. FⅦ gene was amplified by PCR and inserted into pOptiVEC vector. Then the recombinant plasmid was transfected into CHO/DG44 cells after being identified by enzyme digestion and sequencing. The obtained positive clones were further screened at different concentrations of MTX. FⅦ protein was purified by affinity chromatography and confirmed by Western-blot and PT. The Results showed that the recombinant plasmid was construct correctly and the positive cell clones could steadily express F Ⅶ which had the coagulation activity.
出处 《四川大学学报(自然科学版)》 CAS CSCD 北大核心 2015年第3期673-676,共4页 Journal of Sichuan University(Natural Science Edition)
基金 国家自然科学基金项目(31371325)
关键词 人凝血因子Ⅶ 真核表达 CHO/DG44细胞 凝血活性 Human coagulation factorⅦ (FⅦ), eukaryotic expression, CHO/DG44 cell,coagulation ac-tivity
  • 相关文献

参考文献2

二级参考文献36

  • 1孙立忠,常谦,胡晓鹏,朱俊明,于存涛,刘志刚.一期次全或全主动脉替换术的临床应用[J].中华外科杂志,2005,43(22):1425-1428. 被引量:17
  • 2Veldman A,Hoffman M,Ehrenforth S.New insight into the coagulation system and amplification for new therapeutic options with recombinant factor Ⅶa.Current Medicinal Chemistry,2003,10(10):797-811.
  • 3Monroe DM,Hoffman M,Roberts HR.Platelets and thrombin generation.Art Thromb Vasc Biol,2002,22(9): 1381-1389.
  • 4Hoffman M,Monroe DM.A cell-based model of hemostasis. Thromb Haemost,2001,85(6):958-965.
  • 5Hedner U. Recombinant factor Ⅶa:its background, development and clinical use.Curr Opin Hematol,2007,14 (3):225-229.
  • 6Al-Ruzzeh S,Navia JL.The“off-label”role of recombinant factorⅦa in surgery:is the problem deficient evidence or defective concept.J Am Coll Surg,2009,209(5):659-667.
  • 7Viuff D,Lauritzen B,Pusateri AE,et al.Effect of haemodilution,acidosis,and hypothermia on the activity of recombinant factorⅦa(NovoSeven).Br J Anaesth,2008, 101(3):324-331.
  • 8Meng ZH,Wolberg AS,Monroe DM 3rd,et al.The effect of temperature and pH on the activity of factor Ⅶa in hypothermic and acidotic patients.J Trauma,2003,55(5): 886-891.
  • 9Knudson MM,Cohen MJ,Reidy R,et al.Trauma, transfusion and use of recombinant factorⅦa:a multicenter case registry report of 380patients from the western trauma association.J Am Coll Surg,2011,212(1):87-95.
  • 10Clark AD,Gordon WC,Walter ID,et al.“Last-ditch”use of recombinant factorⅦa in patients with massive haemorrhage is ineffective.Vox Sang,2004,86(2):120-124.

共引文献1

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部